Log in or Sign up for Free to view tailored content for your specialty!
Skin Disorders News
Sienna Biopharmaceuticals acquires drug candidates for treating psoriasis, atopic dermatitis
Sienna Biopharmaceuticals announced it has acquired Creabilis plc, a specialty pharmaceutical company focused on developing topical treatments for inflammatory skin conditions, including psoriasis, atopic dermatitis and pruritus.
Target lesions, symptoms not always indicative of Lyme disease
NEW YORK — Symptoms alone are not enough reason to test a patient for Lyme disease, and not every patient with Lyme disease will present with target lesions, according to a presentation at the 2016 Infectious Diseases in Children Symposium.
Log in or Sign up for Free to view tailored content for your specialty!
Wide variation exists in prescribing practices of systemic agents for pediatric atopic dermatitis
A survey of physicians in the United States and Canada found that there is great variation in prescribing practices of systemic agents to treat atopic dermatitis, according to results published in the Journal of the American Academy of Dermatology.
Adults with atopic dermatitis susceptible to autoimmune diseases
Adults with atopic dermatitis had a higher susceptibility of autoimmune diseases compared with controls, with a significantly higher occurrence in smokers, according to recently published results of a population-based study.
Mortality lower for patients hospitalized for atopic dermatitis compared with psoriasis
Patients who were hospitalized for atopic dermatitis had a significantly lower 10-year mortality compared with patients hospitalized for psoriasis, but an increased mortality compared with the general population, according to recently published study results.
Self-reports of allergy unreliable in parents of children with food allergies
Few parents of children with food allergies who self-report a current food allergy were actually found to have sensitivity to the reported allergen, according to study results published in the Annals of Allergy, Asthma and Immunology.
Second Genome, King's College London study eczema, food allergies in infants
Second Genome has announced it is partnering with King’s College London to conduct microbiome profiling and analysis for a study in eczema and food allergies in young children.
Dupixent shows efficacy in treating atopic dermatitis
Adults with atopic dermatitis who were treated with Dupixent in two identical phase 3 trials experienced improvement in severity of disease and in symptoms including pruritus, anxiety and depression, according to study results recently published in The New England Journal of Medicine.
Atopic dermatitis negatively impacts patients socially and psychologically, survey reports
Adults with moderate-to-severe atopic dermatitis reported that the disease impacted their lives socially and psychologically, according to survey results.
Provider-based data reveal greater asthma, reduced eczema rates
Provider-based diagnosis data yielded an association between food allergy and the development of respiratory allergy, along with lower rates of eczema and higher rates of asthma than previously reported, according to published findings.